tiprankstipranks
Dr. Reddy's Laboratories Ltd (RDY)
NYSE:RDY
US Market

Dr Reddy's Laboratories (RDY) Income Statement

Compare
417 Followers

Dr Reddy's Laboratories Income Statement

Last quarter (Q3 2025), Dr Reddy's Laboratories's total revenue was ₹83.59B, an increase of 15.85% from the same quarter last year. In Q3, Dr Reddy's Laboratories's net income was ₹14.13B. See Dr Reddy's Laboratories’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
₹ 279.16B₹ 245.88B₹ 214.39B₹ 189.72B₹ 174.60B
Gross Profit
₹ 163.61B₹ 202.97B₹ 113.84B₹ 103.08B₹ 94.01B
Operating Expenses
₹ 95.88B₹ 117.61B₹ 76.80B₹ 70.12B₹ 61.25B
Depreciation and Amortization
₹ 14.84B₹ 12.64B₹ 11.82B₹ 12.80B₹ 12.47B
EBITDA
₹ 88.42B₹ 74.43B₹ 47.74B₹ 45.71B₹ 41.78B
Operating Income
₹ 67.73B₹ 96.28B₹ 40.82B₹ 36.06B₹ 37.05B
Other Income/Expenses
₹ 4.14B₹ 3.34B₹ 2.82B₹ 4.04B₹ 2.04B
Pretax Income
₹ 71.87B₹ 60.48B₹ 32.30B₹ 28.32B₹ 18.03B
Net Income
₹ 55.68B₹ 45.07B₹ 23.57B₹ 17.24B₹ 19.50B
Per Share Metrics
₹ ―₹ ―₹ ―₹ ―₹ ―
Basic EPS
₹ 66.80₹ 271.47₹ 142.08₹ 103.94₹ 117.62
Diluted EPS
₹ 66.80₹ 270.90₹ 141.69₹ 103.65₹ 117.40
Weighted Average Shares Outstanding
833.54M 166.03M 165.88M 165.84M 165.76M
Weighted Average Shares Outstanding (Diluted)
833.54M 166.38M 166.34M 166.32M 166.08M
Currency in INR

Dr Reddy's Laboratories Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis